These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31814953)

  • 1. Set-up and screening of a fragment library targeting the 14-3-3 protein interface.
    Valenti D; Neves JF; Cantrelle FX; Hristeva S; Lentini Santo D; Obšil T; Hanoulle X; Levy LM; Tzalis D; Landrieu I; Ottmann C
    Medchemcomm; 2019 Oct; 10(10):1796-1802. PubMed ID: 31814953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical and computational fragment-based approaches to targeting protein-protein interactions: applications in structure-guided drug discovery.
    Winter A; Higueruelo AP; Marsh M; Sigurdardottir A; Pitt WR; Blundell TL
    Q Rev Biophys; 2012 Nov; 45(4):383-426. PubMed ID: 22971516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Two Secondary Ligand Binding Sites in 14-3-3 Proteins Using Fragment Screening.
    Sijbesma E; Skora L; Leysen S; Brunsveld L; Koch U; Nussbaumer P; Jahnke W; Ottmann C
    Biochemistry; 2017 Aug; 56(30):3972-3982. PubMed ID: 28681606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical candidates modulating protein-protein interactions: The fragment-based experience.
    Valenti D; Hristeva S; Tzalis D; Ottmann C
    Eur J Med Chem; 2019 Apr; 167():76-95. PubMed ID: 30769242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Allosteric Modulators of Voltage-Gated Na
    Dvorak NM; Wadsworth PA; Wang P; Zhou J; Laezza F
    Curr Top Med Chem; 2021; 21(10):841-848. PubMed ID: 34036922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-based Differential Targeting of PPI Stabilizer Interfaces.
    Guillory X; Wolter M; Leysen S; Neves JF; Kuusk A; Genet S; Somsen B; Morrow JK; Rivers E; van Beek L; Patel J; Goodnow R; Schoenherr H; Fuller N; Cao Q; Doveston RG; Brunsveld L; Arkin MR; Castaldi P; Boyd H; Landrieu I; Chen H; Ottmann C
    J Med Chem; 2020 Jul; 63(13):6694-6707. PubMed ID: 32501690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
    Ni D; Lu S; Zhang J
    Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hotspot Identification and Drug Design of Protein-Protein Interaction Modulators Using the Fragment Molecular Orbital Method.
    Monteleone S; Fedorov DG; Townsend-Nicholson A; Southey M; Bodkin M; Heifetz A
    J Chem Inf Model; 2022 Aug; 62(16):3784-3799. PubMed ID: 35939049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-based drug discovery supports drugging 'undruggable' protein-protein interactions.
    Wang ZZ; Shi XX; Huang GY; Hao GF; Yang GF
    Trends Biochem Sci; 2023 Jun; 48(6):539-552. PubMed ID: 36841635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulators of 14-3-3 Protein-Protein Interactions.
    Stevers LM; Sijbesma E; Botta M; MacKintosh C; Obsil T; Landrieu I; Cau Y; Wilson AJ; Karawajczyk A; Eickhoff J; Davis J; Hann M; O'Mahony G; Doveston RG; Brunsveld L; Ottmann C
    J Med Chem; 2018 May; 61(9):3755-3778. PubMed ID: 28968506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.
    Hua Y; Shun TY; Strock CJ; Johnston PA
    Assay Drug Dev Technol; 2014 Sep; 12(7):395-418. PubMed ID: 25181412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Des3PI: a fragment-based approach to design cyclic peptides targeting protein-protein interactions.
    Delaunay M; Ha-Duong T
    J Comput Aided Mol Des; 2022 Aug; 36(8):605-621. PubMed ID: 35932404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptor-Specific Antibody Fragment Inhibitors for the Intracellular Modulation of p97 (VCP) Protein-Protein Interactions.
    Jiang Z; Kuo YH; Zhong M; Zhang J; Zhou XX; Xing L; Wells JA; Wang Y; Arkin MR
    J Am Chem Soc; 2022 Jul; 144(29):13218-13225. PubMed ID: 35819848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Space Overlap with Critical Protein-Protein Interface Residues in Commercial and Specialized Small-Molecule Libraries.
    Si Y; Xu D; Bum-Erdene K; Ghozayel MK; Yang B; Clemons PA; Meroueh SO
    ChemMedChem; 2019 Jan; 14(1):119-131. PubMed ID: 30548204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment-Based Stabilizers of Protein-Protein Interactions through Imine-Based Tethering.
    Wolter M; Valenti D; Cossar PJ; Levy LM; Hristeva S; Genski T; Hoffmann T; Brunsveld L; Tzalis D; Ottmann C
    Angew Chem Int Ed Engl; 2020 Nov; 59(48):21520-21524. PubMed ID: 32816380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Small-Molecule Stabilizers of 14-3-3 Protein-Protein Interactions via Dynamic Combinatorial Chemistry.
    Hartman AM; Elgaher WAM; Hertrich N; Andrei SA; Ottmann C; Hirsch AKH
    ACS Med Chem Lett; 2020 May; 11(5):1041-1046. PubMed ID: 32435423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein-Protein Interactions?
    Dias DM; Van Molle I; Baud MG; Galdeano C; Geraldes CF; Ciulli A
    ACS Med Chem Lett; 2014 Jan; 5(1):23-28. PubMed ID: 24436777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.
    Wu B; Barile E; De SK; Wei J; Purves A; Pellecchia M
    Curr Top Med Chem; 2015; 15(20):2032-42. PubMed ID: 25986689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.